Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 35 Carcinoma, Non-Small-Cell Lung 11 Colorectal Neoplasms 8 Carcinoma, Renal Cell 7 Neoplasms 6 Uveal Melanoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 5 Lymphoma, T-Cell, Cutaneous 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Large-Cell, Anaplastic 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Burkitt Lymphoma 5 Waldenstrom Macroglobulinemia 4 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Sezary Syndrome 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Mycosis Fungoides 4 Intraocular Lymphoma 4 Immunoblastic Lymphadenopathy 4 Hodgkin Disease 4 Carcinoma, Transitional Cell 4 Breast Neoplasms 4

Interventions

pembrolizumab 3 Paclitaxel 2 relatlimab 1 nintedanib 1 lifileucel 1 dabrafenib 1 Vitamin D 1 Temozolomide 1 Surveys and Questionnaires 1 Opdualag 1 Nivolumab 1 Microarray Analysis 1 Ipilimumab 1 Genetic Testing 1 Gene Expression Profiling 1 Eye Movement Desensitization Reprocessing 1 Electrochemotherapy 1 Dacarbazine 1 Cholecalciferol 1 Carboplatin 1 Biopsy 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma, Cutaneous Malignant × Carboplatin × Dermatologic × Clear all

NCT06743126 2026-06-10

SUPRAME

Immatics US, Inc.

Phase 3 Recruiting

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡